CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,776 | $8.51 | $24K | 3,076 |
| 2020-08-03 | Lunger John Chief Patient Supply Officer | Sale | −4,823 | $9.25 | $45K | 8,066 |
| 2020-08-03 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Sale | −200,000 | $8.74 | $1.7M | 0 |
| 2020-08-03 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,788 | $9.25 | $26K | 3,064 |
| 2020-07-01 | Behbahani Ali Director | Grant or award · Option to purchase Ordinary Shares | +184,258 | 184,258 | ||
| 2020-07-01 | Zaks Tal Zvi Director | Grant or award · Option to purchase Ordinary Shares | +144,000 | 144,000 | ||
| 2020-07-01 | Alleva Lawrence M Director | Grant or award · Option to purchase Ordinary Shares | +197,678 | 197,678 | ||
| 2020-07-01 | Furey John Director | Grant or award · Option to purchase Ordinary Shares | +196,186 | 196,186 | ||
| 2020-07-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +179,785 | 179,785 | ||
| 2020-07-01 | Sigal Charles Elliott Director | Grant or award · Option to purchase Ordinary Shares | +184,258 | 184,258 | ||
| 2020-07-01 | MOTT DAVID M Director | Grant or award · Option to purchase Ordinary Shares | +226,753 | 226,753 | ||
| 2020-07-01 | Duncan Barbara Gayle Director | Grant or award · Option to purchase Ordinary Shares | +144,000 | 144,000 | ||
| 2020-06-29 | Wood Gavin Chief Financial Officer | Purchase | +33,000 | $1.62 | $53K | 33,000 |
| 2020-06-09 | Alleva Lawrence M Director | Purchase | +12,900 | $1.89 | $24K | 12,900 |
| 2020-05-29 | Noble James Director | Sale | −500,000 | $9.33 | $4.7M | 0 |
| 2020-04-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +31,000 | 31,000 | ||
| 2020-04-01 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +2,500,000 | 2,500,000 | ||
| 2020-04-01 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +565,000 | 565,000 | ||
| 2020-01-24 | Sonsini Peter W. 10% owner | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
| 2020-01-24 | SANDELL SCOTT D 10% owner | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
Page 13 of 23 · 454 trades